Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
26/12/200722h15PR Newswire (US)Insmed to Appeal Delisting Notification From NasdaqNASDAQ:INSMInsmed Inc
18/12/200715h00PR Newswire (US)Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular DystrophyNASDAQ:INSMInsmed Inc
13/12/200713h04Edgar (US Regulatory)Insmed Inc - Current report filing (8-K)NASDAQ:INSMInsmed Inc
12/12/200722h29Edgar (US Regulatory)Insmed Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
12/12/200715h00PR Newswire (US)Insmed Awarded $2.1 Million by Muscular Dystrophy AssociationNASDAQ:INSMInsmed Inc
06/12/200722h15PR Newswire (US)Insmed Appoints Dennis M. Lanfear to Board Of DirectorsNASDAQ:INSMInsmed Inc
06/12/200715h00PR Newswire (US)Insmed to Present at the IBC 5th Annual Global Follow-On Biologics ConferenceNASDAQ:INSMInsmed Inc
03/12/200715h15PR Newswire (US)Insmed Retains FD and Gibraltar Associates for Investor Relations and Corporate CommunicationsNASDAQ:INSMInsmed Inc
15/11/200721h21Edgar (US Regulatory)Insmed Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
09/11/200722h08Edgar (US Regulatory)Insmed Inc - Quarterly Report (10-Q)NASDAQ:INSMInsmed Inc
02/08/200715h15Business WireInsmed Reports Financial Results for Second Quarter and First Half of 2007NASDAQ:INSMInsmed Inc
25/07/200715h15Business WireInsmed Announces Second Quarter and First Half Earnings Release Date and Conference CallNASDAQ:INSMInsmed Inc
09/07/200715h00Business WireInsmed Inc. to Present at C.E. Unterberg, Towbin Growth ConferenceNASDAQ:INSMInsmed Inc
26/06/200715h15Business WireInsmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature InfantsNASDAQ:INSMInsmed Inc
25/06/200715h00Business WireExperienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on BiologicsNASDAQ:INSMInsmed Inc
19/06/200722h15Business WireInsmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid PriceNASDAQ:INSMInsmed Inc
10/05/200715h00Business WireInsmed Incorporated Reports Financial Results for First Quarter Ended March 31, 2007NASDAQ:INSMInsmed Inc
08/05/200702h00Business WireInsmed Announces First Quarter Earnings Release Date and Conference CallNASDAQ:INSMInsmed Inc
04/05/200715h05Business WireInsmed Raises Approximately $18.2 Million in Registered Direct OfferingNASDAQ:INSMInsmed Inc
03/05/200715h15Business WireInsmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical StudyNASDAQ:INSMInsmed Inc
02/05/200715h00Business WireInsmed CEO Geoffrey Allan Testifies at Energy and Commerce Committee HearingNASDAQ:INSMInsmed Inc
30/04/200715h00Business WireInsmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical StudyNASDAQ:INSMInsmed Inc
25/04/200715h01Business WireInsmed Inc. Releases Investor Fact Sheet with Updates on Drug Development ProgressNASDAQ:INSMInsmed Inc
26/03/200715h32Business WireInsmed CEO Geoffrey Allan Testifies at Congressional HearingNASDAQ:INSMInsmed Inc
16/03/200721h02Business WireInsmed Announces Additional Information In Compliance With NASDAQ RulesNASDAQ:INSMInsmed Inc
15/03/200721h00Business WireInsmed Inc. Reports Financial Results for Fourth Quarter and Twelve MonthsNASDAQ:INSMInsmed Inc
10/03/200718h11Business WireUpdate: Insmed to Hold 2006 Q4 and Year End Earnings ResultsNASDAQ:INSMInsmed Inc
09/03/200723h21Business WireInsmed to Hold 2006 Q4 and Year End Earnings ResultsNASDAQ:INSMInsmed Inc
07/03/200716h51Business WireInsmed Announces Restructure, Settlement Ending IPLEX(TM) Patent DisputeNASDAQ:INSMInsmed Inc
07/03/200705h24Business WireInsmed to Discuss Litigation Settlement with TercicaNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM